Productivity · Cited evidence brief
NovoScribe assists regulated document writing
90%
less clinical-study-report writing time, reported in a vendor case study
Deployed workflow; measurement period not disclosed
A supplier-hosted account of a deployed customer workflow. Customer claims and supplier attribution are not independent validation; inspect the method and limits.
Reported facts · from the source
- Value
- 90%
- What was measured
- less clinical-study-report writing time, reported in a vendor case study
- Period
- Deployed workflow; measurement period not disclosed
- Baseline
- Not stated in the reviewed source summary
- Original industry
- Pharmaceuticals
- Scope
- Clinical-study-report writing in NovoScribe; human review and approval are subsequent workflow stages.
- Evidence kind
- Vendor case study
90%
less clinical-study-report writing time, reported in a vendor case study
Deployed workflow; measurement period not disclosed
Scope, baseline & source
- Scope / denominator
- Clinical-study-report writing in NovoScribe; human review and approval are subsequent workflow stages.
- Baseline
- Not disclosed in this account
- Claim basis
- Vendor case study
Supplier-hosted customer claim with no sample, error rate or costing method. Minutes-to-generate headlines concern document production, not the complete clinical/regulatory approval cycle or drug discovery. Legacy-data integrations required substantial work.
Read claim source ↗Measures retain their original currency, scope and period. Capacity, adoption and forecasts are not realized cash savings.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsWhat the source reports
A Novo Nordisk executive describes 90% less clinical-study-report writing time using NovoScribe, which combines Claude, retrieval, expert-approved text and case data. Human review and approval follow document generation.
How to read this number
Supplier-hosted customer claim with no sample, error rate or costing method. Minutes-to-generate headlines concern document production, not the complete clinical/regulatory approval cycle or drug discovery. Legacy-data integrations required substantial work.
Human controls and constraints
Stated in the source summary or the editorial caveat.
- Human review and approval remain required
- Writing time is distinct from accepted-document cycle time
- No independent regulator validation or measured FS effect
Brief reviewed Oct 26, 2026 against the primary source above. The review date is separate from the source publication date and measurement period. Not independently audited.